NASDAQ:BYSI - Beyondspring Stock Price, Forecast & News

Beyondspring trades on the NASDAQ under the ticker symbol "BYSI."

Beyondspring Inc (NASDAQ:BYSI) announced its earnings results on Wednesday, September, 18th. The company reported ($0.32) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.27) by $0.05. View Beyondspring's Earnings History.

Beyondspring is scheduled to release their next quarterly earnings announcement on Tuesday, December 10th 2019. View Earnings Estimates for Beyondspring.

3 analysts have issued 12-month price objectives for Beyondspring's stock. Their forecasts range from $41.00 to $41.00. On average, they expect Beyondspring's share price to reach $41.00 in the next twelve months. This suggests a possible upside of 194.1% from the stock's current price. View Analyst Price Targets for Beyondspring.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beyondspring in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Beyondspring.

Media coverage about BYSI stock has been trending extremely positive this week, according to InfoTrie Sentiment. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Beyondspring earned a media sentiment score of 5.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Beyondspring.

Beyondspring saw a drop in short interest during the month of October. As of October 31st, there was short interest totalling 482,900 shares, a drop of 13.3% from the September 30th total of 557,000 shares. Based on an average trading volume of 52,500 shares, the days-to-cover ratio is currently 9.2 days. Approximately 5.7% of the company's shares are short sold. View Beyondspring's Current Options Chain.

Some companies that are related to Beyondspring include Aurinia Pharmaceuticals (AUPH), Epizyme (EPZM), Innoviva (INVA), Y-mAbs Therapeutics (YMAB), Esperion Therapeutics (ESPR), Arvinas (ARVN), Athenex (ATNX), Enanta Pharmaceuticals (ENTA), BELLUS Health (BLUSF), Principia Biopharma (PRNB), Theravance Biopharma (TBPH), Supernus Pharmaceuticals (SUPN), ArQule (ARQL), NextCure (NXTC) and Wave Life Sciences (WVE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Beyondspring investors own include Exelixis (EXEL), ImmunoGen (IMGN), Mallinckrodt (MNK), ACADIA Pharmaceuticals (ACAD), Amarin (AMRN), Athenex (ATNX), Atara Biotherapeutics (ATRA), Accelerate Diagnostics (AXDX), Cidara Therapeutics (CDTX) and Celgene (CELG).

(BYSI) raised $4 million in an initial public offering on Thursday, March 9th 2017. The company issued 200,000 shares at $20.00 per share. Rodman & Renshaw (a Unit of H.C. Wainwright & Co.) served as the underwriter for the IPO.

Beyondspring's stock is owned by a variety of of retail and institutional investors. Top institutional investors include State Street Corp (0.60%), Tanaka Capital Management Inc. (0.18%), Russell Investments Group Ltd. (0.14%), California State Teachers Retirement System (0.07%), Barclays PLC (0.04%) and Nisa Investment Advisors LLC (0.03%).

BYSI stock was sold by a variety of institutional investors in the last quarter, including Tanaka Capital Management Inc..

BYSI stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., State Street Corp, Nisa Investment Advisors LLC, Barclays PLC and California State Teachers Retirement System.

Shares of BYSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BYSI stock can currently be purchased for approximately $13.94.

Beyondspring has a market capitalization of $361.88 million. The company earns $-54,870,000.00 in net income (profit) each year or ($2.42) on an earnings per share basis. View Additional Information About Beyondspring.

The official website for Beyondspring is http://www.beyondspringpharma.com/.

Beyondspring's mailing address is 28 LIBERTY STREET 39TH FLOOR, NEW YORK NY, 10005. The company can be reached via phone at 1-646-305-6387 or via email at [email protected]